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The antioxidant enzyme superoxide dismutase 1
(SOD1) is a critical player of the antioxidative defense
whose activity is altered in several chronic diseases,
including amyotrophic lateral sclerosis. However,
how oxidative insult affects muscle homeostasis re-
mains unclear. This study addresses the role of oxi-
dative stress on muscle homeostasis and function
by the generation of a transgenic mouse model ex-
pressing amutant SOD1 gene (SOD1G93A) selectively
in skeletal muscle. Transgenic mice developed pro-
gressive muscle atrophy, associated with a signifi-
cant reduction in muscle strength, alterations in the
contractile apparatus, and mitochondrial dysfunc-
tion. The analysis of molecular pathways associated
with muscle atrophy revealed that accumulation of
oxidative stress served as signaling molecules to ini-
tiate autophagy, one of the major intracellular degra-
dation mechanisms. These data demonstrate that
skeletal muscle is a primary target of SOD1G93A -me-
diated toxicity and disclose the molecular mecha-
nism whereby oxidative stress triggers muscle
atrophy.
INTRODUCTION
The delicate balance between oxidant production and antioxi-
dant defense is severely compromised in several pathological
conditions, leading to muscle wasting (Moylan and Reid, 2007).
The fact that mutation in the major antioxidant enzyme superox-
ide dismutase 1 (SOD1) is associated with one fifth of familial
amyotrophic lateral sclerosis (ALS) has implicated oxidative
stress as a key mechanism underlying the pathogenesis of thisCelldisease (Barber et al., 2006). ALS is an adult-onset disease
that is characterized by the selective degeneration of motor neu-
rons in the brain and spinal cord, resulting in progressive paral-
ysis and death.
Although mutant SOD1 is also expressed by muscle, it is not
yet established whether its presence in skeletal muscle directly
contributes to any pathological feature, including muscle atro-
phy and alteration in the functional performance. To date, alter-
ations in ALS skeletal muscle have been considered the result of
alterations in nerve activity and not the direct result of SOD1-
mediated toxicity.
It has been reported that partial suppression of mutant SOD1
accumulation within muscle (50% decrease in SOD1 mRNA and
protein in the muscle fibers) (Miller et al., 2006) was not sufficient
to delay the progression of the disease in the SOD1G93A mouse,
suggesting that residual mutant protein is sufficient to retain the
pathological phenotype or that muscle is not a key component in
pathogenesis of ALS.
To explore more directly whether skeletal muscle is a direct
target of SOD1-mediated toxicity and to determine the specific
contribution of oxidative stress to muscle atrophy and wasting,
we generated transgenic mice in which the SOD1 mutant gene
(SOD1G93A) was selectively expressed in skeletal muscle under
the transcriptional control of muscle-specific promoter (MLC)
(Grieshammer et al., 1992). This approach dissociates the alter-
ations of skeletal muscle from motor neuron degeneration and
allows definition of the intracellular signal perturbations activated
by muscle-specific impairment of the antioxidant SOD1 enzyme.
We show that muscle-restricted expression of the SOD1G93A
(MLC/SOD1G93A) transgene was sufficient to induce severe
muscle atrophy associated with significant reduction in muscle
strength, sarcomere disorganization, significant changes in mi-
tochondria morphology and disposition, and disorganization of
the sarcotubular system. Analysis of signals activated by selec-
tive muscle accumulation of oxidative stress in MLC/SOD1G93A
transgenic mice revealed that along with the activation of FoxOMetabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc. 425
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Oxidative Stress Induces Muscle Atrophyand NFkB, both of which induce the expression of several atro-
phy-related genes, the accumulation of reactive oxygen species
(ROS) served as signaling to initiate autophagy, one of the major
intracellular degradation mechanisms that appears to be a key
determinant for the induction of muscle atrophy. Ultrastructural
analysis of MLC/SOD1G93A muscle revealed the T-tubule as
the potential donor of membrane that forms sequestering auto-
phagocytic vesicles. The characterization of this mouse model
and elucidation of the molecular mechanism that mediates mus-
cle atrophy promises to significantly advance our understanding
of the possible pathogenic mechanisms of oxidative stress that
leads to muscle wasting in human diseases.
RESULTS
Selective Expression of Mutant SOD1G93A Gene
in Skeletal Muscle
To define the direct contribution of oxidative stress on muscle at-
rophy and wasting and verify whether skeletal muscle is a direct
target of SOD1 mutation we generated transgenic mice with the
mutated isoform of human superoxide dismutase 1 (SOD1G93A)
cDNA driven by skeletal muscle-specific regulatory elements
from the rat myosin light chain (MLC)-1/3 locus (Grieshammer
et al., 1992) (Figure 1A). Expression of the MLC/SOD1G93A trans-
gene in adult mice was restricted to skeletal muscle, predomi-
nated in muscles enriched in fast fibers, and reduced in slow
muscles such as the soleus (Figures 1B and 1C), where the
MLC regulatory cassette is characteristically expressed at very
low levels (Grieshammer et al., 1992). Notably, no expression
of human SOD1 protein and transcript were found in heart, brain,
Figure1. CharacterizationofMLC/SOD1G93A
Transgenic Mice
(A) Schematic representation of MLC/SOD1G93A
construct.
(B) Western blot analysis for human SOD1 protein in
different tissues of both WT () and MLC/
SOD1G93A trangenic (+) mice.
(C) Northern blot analysis of total RNA samples
(15 mg) from heart, brain, liver, spleen, and different
skeletal muscles of both wild-type (WT) and trans-
genic mice was carried out with PolyA SV40 32P-
labeled probe. Ethidium bromide staining was
used to verify equal loading of the RNA. MLC/
SOD1G93A protein (B) and transcripts (C) are re-
stricted to the fastest muscle types in transgenic
mice and are undetectable in WT muscles.
(D) Western blot analysis for human SOD1 protein
in TA, EDL, and soleus muscle of SOD1G93A and
MLC/SOD1G93A mice.
liver, spleen, or spinal cord (Figures 1B
and 1C) of transgenic mice.
Western blot analysis (Figure 1D) also
revealed that the levels of mutant SOD1
synthesis in tibialis anterior (TA) and ex-
tensor digitorum longus (EDL) muscles
of MLC/SOD1G93A adult mice were simi-
lar to the corresponding levels found in
mice that develop ALS-like disease from
ubiquitous expression of the same G93A mutant (Gurney et al.,
1994). In contrast, soleus muscle of the classical SOD1G93A
mouse expressed higher levels of SOD1 mutant gene, compared
to the corresponding muscle of MLC/SOD1G93A mice (Figures
1B–1D), consistent with the fast fiber-selective pattern of endog-
enous MLC expression.
Muscle-Restricted Expression of SOD1G93A Protein
Causes Muscle Atrophy
To verify whether local accumulation of mutant SOD1 protein al-
tered the muscle phenotype, we performed histological analysis
on skeletal muscles of 10-day-old (neonatal), 4-week-old (young),
and 16-week-old (adult) transgenic mice. While hematoxylin and
eosin staining did not reveal significant differences in muscle
mass between wild-type (WT) and transgenic mice at 10 days
old (data not shown), skeletal muscle atrophy in MLC/SOD1G93A
mice was first detectable at 4 weeks (Figures 2A and 2B), increas-
ing into adulthood (16 weeks), when the transgenic mice showed
significant reduction in cross-sectional area (CSA) of TA, soleus,
and EDL muscle fibers compared with their age-matched WT sibs
(Figures 2C and 2D). Notably, the relatively lower expression
levels of MLC/SOD1G93A transgene in soleus muscle, compared
to EDL and TA (Figures 1B and 1C), were still sufficient to induce
muscle atrophy (Figure 2C), supporting the evidence that
SOD1G93A toxic properties are independent of the levels of
SOD1 activity. The frequency distribution of CSA (Figures 2B
and 2D) revealed a shift of the median values toward the small
size of muscle fibers in all muscles analyzed. Of note, WT MLC/
SOD1 overexpression did not induce evident signs of muscle at-
rophy and any morphological sign of disease (data not shown).426 Cell Metabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc.
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Oxidative Stress Induces Muscle AtrophyFigure 2. MLC/SOD1G93A Expression Induces Severe Skeletal Muscle Atrophy
(A) Haematoxylin and eosin-stained cross-sections of tibialis anterior (TA) muscles from 1-month-old wild-type (WT) and MLC/SOD1G93A transgenic (Tg) mice.
Bar = 100 mm.
(B) Fiber size in WT (white bars) (n = 5) and MLC/SOD1G93A transgenic (black bars) (n = 5) mice of TA muscles (mean ± SEM; TA WT = 1581.6 ± 22.2 mm2; TA
Tg = 1293.7 ± 10.7 mm2. Mann-Whitney Rank Sum test: p < 0.001).
(C) Haematoxylin and eosin-stained cross-sections of TA, soleus, and EDL muscles from 4-month-old WT and MLC/SODG93A transgenic (Tg) mice. Bar = 100 mm.
(D) Fiber size in wild-type (white bars) (n = 5) and MLC/SOD1G93A transgenic (black bars) (n = 5) mice of TA (upper panel), soleus (central panel), and EDL (lower
panel) muscles (mean ± SEM; TA WT = 2073.3 ± 38.1 mm2; TA Tg = 1503.8 ± 25.3 mm2; Soleus WT = 1099.2 ± 18.9 mm2; Soleus Tg = 991.6 ± 15.1 mm2;; EDL WT =
1274.6 ± 44.5 mm2; EDL Tg = 993.9 ± 40.3 mm2. Mann-Whitney Rank Sum test: p < 0.001).MutantSOD1Alters the Functional Performance and the
Contractile andMetabolic Machinery of Skeletal Muscle
To determine whether muscle accumulation of SOD1G93A mu-
tant protein affected the capacity to produce force, a direct com-
parison of mechanical parameters was performed for the soleus
and EDL muscles of both WT and MLC/SOD1G93A transgenic
mice at 16 weeks of age. Muscle atrophy in transgenic mice
was associated with decreased tetanic and specific force gener-
ation of 37% for EDL and 39% for soleus muscle compared with
age-matched WT littermates (Figures 3A, 3B, 3D, and 3E). This
trend was confirmed by the analysis of isotonic fatigue. In the
first seconds of fatigue, stimulation of both transgenic EDL and
soleus produced work of about 38% less than WT muscles (Fig-
ures 3C and 3F). Furthermore, MLC/SOD1G93A EDL and soleus
stopped shortening about 7 s and 15 s, respectively, beforeCell Mthe WT controls. These analyses demonstrate that even low
levels of mutant SOD1G93A transgene expression, such as those
in the soleus muscle, were sufficient to compromise the morpho-
logical and functional parameters of skeletal muscle.
The altered muscle phenotype of the MLC/SOD1G93A mice
was confirmed by ultrastructural analysis. In electron micros-
copy (EM), adult skeletal muscle fibers are characterized by
a highly ordered organization of their major apparatii (Franzini-
Armstrong, 1970): the contractile apparatus (the myofibrils), the
excitation-contraction (EC) coupling units (formed by the sarco-
tubular system), and the metabolic machinery (the mitochon-
dria), which are usually regularly shaped with a dark/dense
internal matrix and specifically positioned between the Z lines
and triads (Ogata and Yamasaki, 1985). Fibers in EDL muscles
from MLC/SOD1G93A transgenic mice showed clear alterationsetabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc. 427
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Oxidative Stress Induces Muscle AtrophyFigure 3. MLC/SOD1G93A Expression Affects the Functional Performance of Skeletal Muscle
(A–F) Physiological properties of EDL and soleus muscles from 4-month-old WT and Tg mice. EDL (upper panels) and soleus muscles (lower panels) from
wild-type (n = 10) and transgenic (n = 10) mice were compared by tetanic force (left), specific force (center), and work (right). All measurements are presented
as mean ± SEM (*p = 0.022; **p = 0.0015; ***p < 0.0001).
(G) Electron microscopy of MLC/SOD1G93A EDL muscles. In MLC/SOD1G93A transgenic muscle, myofibrils were often out of register (panel a, black arrows), and
mitochondria were clustered in longitudinal rows between the myofibrils (panel a, empty arrows). Mitochondria were swollen (panel a, stars), abnormally shaped,
and larger in size (panel b, giant mitochondria). In several cases abnormal mitochondria contained vacuolization (panel c, stars), disrupted external membrane
(panel c, dashed box and enlarged detail), and large myelin-like figures (panel e, empty star). Large clusters of mitochondria located just under the sarcolemma
(panel d, large arrows) were more frequent in transgenic muscle (panel d, arrowhead). Bars: a and d, 1 mm; b, c, and e, 0.5 mm.
(H) Real-time PCR analysis of PGC1a transcript in both WT and MLC/SOD1G93A transgenic (Tg) muscles (**p = 0.0093). Values are reported as mean ± SEM.
(I) NADH-TR staining of WT and MLC/SOD1G93A (Tg) EDL muscles shows a shift from glycolitic to oxidative metabolism (darker fibers). Bar = 100 mm.of their internal organization, including partial loss or misalign-
ment of sarcomeres, significant changes of mitochondria mor-
phology and of their sarcomeric disposition, and disorganization
of the sarcotubular system (Figure 3G). In these fibers, Z lines of
adjacent myofibrils tended to loose register with one another
(Figure 3Ga, black arrows). Mitochondria were often clustered
in abnormal longitudinal rows between the myofibrils and/or
large clusters located just under the sarcolemma (Figure 3Ga
and 3Gd, empty arrows). In addition, mitochondria were fre-
quently abnormally shaped, were larger in size (Figure 3Gb, giant
mitochondria), and presented a translucent appearance, edem-
atous internal matrix with abnormal and/or missing internal cris-428 Cell Metabolism 8, 425–436, November 5, 2008 ª2008 Elseviertae (Figure 3Gc, dashed box and enlarged detail), vacuolization
(Figure 3Gc), and myelin-like figures (Figure 3Ge). Interestingly,
similar alterations in myofibrillar structure and in mitochondria
disposition have been described in aging skeletal muscle (Bon-
compagni et al., 2006 and data not shown) and in skeletal muscle
biopsies of ALS patients (Chung and Suh, 2002).
The Peroxisome proliferator-activated receptor gamma coac-
tivator 1a (PGC1a) is one of the major regulators of several cru-
cial aspects of energy metabolism. PGC1a controls many as-
pects of oxidative metabolism (St-Pierre et al., 2006), including
mitochondrial biogenesis (Lin et al., 2002), and it is the master
regulatory gene that promotes fiber-type switching fromInc.
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Oxidative Stress Induces Muscle Atrophyglycolytic toward more oxidative fibers (Lin et al., 2002). Real-
time polymerase chain reaction (PCR) revealed that PGC1a ex-
pression was significantly increased in EDL muscle of MLC/
SOD1G93A transgenic mice (Figure 3H).
Notably, the accumulation of PGC1awas also associated with
a shift in the metabolic activity of EDL muscle fibers to a more ox-
idative phenotype in MLC/SOD1G93A transgenic mice, as shown
by greater content of NADH (Figure 3I). Taken together these re-
sults demonstrate that oxidative stress significantly alters the
metabolic activity of skeletal muscles.
Local Expression of SOD1G93A Gene Induces
Sarcolemma Damage
Previous studies (Barber et al., 2006; Mahoney et al., 2006) have
found evidence of increased oxidative stress in ALS patients. El-
evated levels of ROS can damage critical cellular components
such as membrane lipids, structural and regulatory protein,
and DNA (Moylan and Reid, 2007). We analyzed and compared
the presence of oxidative damage in macromolecular substrates
(lipids and proteins) in WT and in two different experimental
transgenic models in which the function of cytosolic antioxidant
enzyme SOD1 was affected: the SOD1G93A transgenic mouse,
which ubiquitously overexpresses mutant SOD1 (Gurney et al.,
1994) and that represents the classical animal model of ALS,
and the MLC/SOD1G93A transgenic mouse described here. Ma-
londialdehyde (MDA) (Figure 4A), a marker of lipid oxidative dam-
age, was elevated in the sarcolemma of transgenic fibers of both
SOD1G93A and MLC/SOD1G93A mice (Figure 4A). The membrane
of the sarcoplasmic reticulum (SR) was significantly affected in
SOD1G93A, but not in MLC/SOD1G93A transgenic muscle
(Figure 4B). Additionally, the content of protein carbonyls, con-
sidered another marker of protein oxidative damage, increased
in SOD1G93A skeletal muscle but not in MLC/SOD1G93A, com-
pared to WT littermates (Figure 4C). These experiments suggest
that alteration of SOD1 protein exclusively in skeletal muscle sig-
nificantly damages the sarcolemma of muscle fibers, without af-
fecting other targets altered by the ubiquitous expression of
SOD1 mutant gene.
Muscle-Specific Expression of SOD1G93A Mutant Gene
Modulates Antioxidant Enzyme Activity
To explore the relationship between SOD1G93A overexpression
and signs of oxidative stress in skeletal muscle, we examined
the main antioxidant enzyme activities, such as gluthathione re-
ductase, gluthathione S-transferase, superoxide dismutase,
and catalase, in muscles of both SOD1G93A and MLC/SOD1G93A
mice. Notably, superoxide dismutase and catalase activity were
significantly increased in both SOD1G93A and MLC/SOD1G93A
muscles compared with WT mouse (Figure 4D). In addition, the
classical SOD1G93A transgenic mouse model displayed an in-
crease in both glutathione S-transferase and glutathione reduc-
tase. In contrast, MLC/SOD1G93A transgenic muscles did not
demonstrate significant changes in glutathione S-transferase ac-
tivity but rather a reduction in glutathione reductase activity com-
pared with WT muscle. These experiments suggest that the
SOD1G93A mutation modulates redox-sensitive signaling cas-
cades and antioxidant defense through distinct muscle-specific
pathways.CellTo further prove that selective accumulation of ROS in skel-
etal muscle is causally linked to the induction of muscle atro-
phy and alteration in muscle strength observed in MLC/
SOD1G93A mice, we inhibited the accumulation of ROS and
verified the potential prevention of SOD1G93A-induced muscle
abnormality.
To this purpose, MLC/SOD1G93A mice were treated, intraper-
itoneally for 15 days, with 30 mg/Kg of Trolox, a cell-permeable
water-soluble derivative of vitamin E with potent antioxidant
properties (Wu et al., 1990; Salgo and Pryor, 1996). Notably, Tro-
lox supplementation significantly reduced the toxic effect of
ROS, rescuing muscle phenotype and the functional perfor-
mance of transgenic muscle (Figures 4E and 4F).
Characterization of Molecular Pathways Involved
in Oxidative Stress-Induced Muscle Atrophy
Transcriptional up- or downregulation of atrophy-related genes
is a characteristic feature of muscle atrophy (Sandri et al.,
2004). The most critical player of muscle atrophy is the transcrip-
tion factor FoxO (Sandri et al., 2004). Western blot analysis re-
vealed a selective accumulation of the dephosphorylated form
of FoxO3 in MLC/SOD1G93A transgenic muscles compared to
WT mice (Figure 5A). The dephosphorylation/activation of
FoxO3 would be expected to lead to upregulation of MAFbx/
atrogin1 and MuRF1, which represent molecular targets of
FoxO activity (Sandri et al., 2004). Surprisingly, quantitative re-
verse transcription polymerase chain reaction (RT-PCR) analysis
revealed that while MuRF1 expression increased in MLC/
SOD1G93A compared to WT mice (Figure 5B), atrogin1 did not
vary significantly between the two experimental models
(Figure 5C), suggesting that FoxO-mediated atrogin1 expression
can be partially repressed and/or other pathways may be in-
volved in the ROS-mediated muscle atrophy. The first hypothe-
sis is supported by the evidence that PGC1a, which increased in
MLC/SOD1G93A muscles (Figure 3H), inhibits FoxO-dependent
transcription on atrogin1 promoter, thereby suppressing atro-
gin1 expression (Sandri et al., 2006).
More recently, it has been also reported that FoxO3 not only
activates ubiquitin ligases but also is necessary and sufficient
for the induction of autophagy, another important intracellular
degradation mechanism, in skeletal muscle (Mammucari et al.,
2007). This pathway is activated and operates under environ-
mental stress conditions and in various pathological situations
(Ohsumi, 2001). In line of this evidence we analyzed the potential
downstream targets of FoxO3, including the autophagic markers
cathepsin L, Bnip3, and LC3B. Cathepsin L is a lysosomal en-
zyme whose role appears to be the degradation of membrane
proteins and that is known to be upregulated during skeletal
muscle atrophy (Judge et al., 2007); Bnip3 is a Bcl-2-related
BH3-only protein involved in the regulation of autophagy by in-
ducing mitochondrial damage and removal via autophagosome
(mitophagy) (Kubli et al., 2007); LC3 is an Atg8 homolog that is
essential for autophagosome formation (Mammucari et al.,
2007) and it is widely used to monitor autophagy.
Real-time RT-PCR analysis revealed that cathepsin L, LC3,
and Bnip3 were significantly upregulated in atrophic muscles
of MLC/SOD1G93A transgenic mice (Figures 5D–5F).
An alternative pathway that may be activated in ROS-medi-
ated muscle atrophy is NFkB, a signaling pathway linked toMetabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc. 429
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Oxidative Stress Induces Muscle AtrophyFigure 4. Mutant SOD1G93A Induces Oxidative Damage in Skeletal Muscle of Transgenic Mice
(A and B) Lipid peroxidation analysis, expressed as nmol of malondialdehyde (MDA) per mg of protein, in sarcolemma (A) and sarcoplasmic reticulum (B) mem-
branes of wild-type (WT) (n = 5), SOD1G93A (n = 5), and MLC/SOD1G93A (Tg) (n = 5) mice. Values are mean ± SEM (*p < 0.05, ***p < 0.0001).
(C) Protein carbonyls assay from muscle of WT (n = 5), SOD1G93A (n = 5), and MLC/SOD1G93A (Tg) (n = 5) mice. The amounts of protein carbonyls are expressed as
nmol of 2,4-dinitrophenylhydrazine (DNPH) per mg of protein. Values are mean ± SEM (*p < 0.05, ***p < 0.0001).
(D) Enzymatic activity of antioxidant enzymes superoxide dismutase 1, catalase, glutathione S-transferase, and glutathione reductase in skeletal muscle of WT
(n = 5), SOD1G93A (n = 5), and MLC/SOD1G93A (Tg) (n = 5) mice. Data are expressed as mean ± SEM (*p < 0.05; **p < 0.0005; ***p < 0.0001).
(E) Top panel: Haematoxylin and eosin-stained cross-sections of TA muscles from WT and MLC/SOD1G93A transgenic untreated (Tg) and treated with Trolox (Tg +
Trolox) mice. Bar = 100 mm. Lower panel: Fiber size in WT (n = 6) and MLC/SOD1G93A transgenic untreated (Tg) (n = 6) and treated (Tg + Trolox) mice of TA muscles
(Mann-Whitney Rank Sum test: p < 0.0001).
(F) Specific force of EDL muscles from 4-month-old WT and transgenic untreated (Tg) and treated (Tg + Trolox) mice. All measurements are presented as mean ±
SEM; **p < 0.002.several pathologic processes in skeletal muscle (Bar-Shai et al.,
2005). We analyzed this alternative pathway based on the inter-
esting evidence that NFkB induces muscle atrophy and wasting,
upregulating MuRF1 but not atrogin1 (Cai et al., 2004; Mourkioti
et al., 2006), and based on the fact that a potential target of NFkB
is cathepsin L (Judge et al., 2007), a lysosomal enzyme that we
saw upregulated in atrophic muscle of MLC/SOD1G93A mice430 Cell Metabolism 8, 425–436, November 5, 2008 ª2008 Elsevier I(Figure 5D). Western blot analysis revealed an increase in the
synthesis and in the phosphorylated form of NFkB protein
(Figure 5G) in the atrophic muscles of MLC/SOD1G93A, com-
pared with WT mice, suggesting that the activation of both
FoxO3 and NFkB converge on the autophagic pathway. Notably,
in MLC/SOD1G93A muscle we did not observe any significant
modulation in apoptotic pathways, such as caspase, which arenc.
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Oxidative Stress Induces Muscle AtrophyFigure 5. Molecular Signature of Muscle Atrophy Induced by MLC/SOD1G93A Expression
(A) Upper panel: Representative western blot analysis of FoxO3 expression in EDL muscle of both wild-type (WT) and MLC/SOD1G93A transgenic (Tg) mice. Lower
panel shows densitometric analysis for FoxO expression.
(B–F) Real-time PCR for MuRF1 (B), atrogin1 (C), cathepsin L (D), LC3 (E), and Bnip3 (F) expression in both WT and MLC/SOD1G93A (Tg) transgenic muscle
(*p = 0.03; ***p < 0.0001).
(G) Upper panels show representative western blot analysis for NFkB and Phospho-NFkB expression in TA muscles of both WT and MLC/SOD1G93A (Tg) mice.
Lower panel shows densitometric analysis for NFkB (lanes 1 and 2) and Phospho-NFkB (lanes 3 and 4) expression (*p < 0.05).
(H) In vivo electrotransfer of siRNA-LC3/GFP construct in TA muscle of MLC/SOD1G93A mice. Left panel shows the CSA of electroporated transgenic
MLC/SOD1G93A muscle.
Right panel shows a representative field of transfected (green–GFPpos and red–GFPpositive stained for anti-GFP antibody) and untransfected (dark–GFP-neg)
fibers. The fibers that integrated the siRNA-LC3/GFP construct resulted in GFP-positive (GFPpos) and display rescue of atrophic phenotype when compared to
wild-type fibers (data not shown). In contrast untransfected GFPneg fibers show the atrophic phenotype, compared with GFPpos fibers (***p < 0.0001). All values
are mean ± SEM.
(I) ElectronMicroscopy ofMLC/SOD1G93A EDLmuscles. Panels a–c showthealtered interactionbetweensarcoplasmic reticulum(SR)andT-tubules. InMLC/SOD1G93A
muscles, SR and T-tubules were altered, with SR abnormally fragmented and the T-tubules forming a vacuole-like structure that encloses amorphous cytoplasmic
material (a–c). Top left of panel c shows an area of muscle fibers in which SR and T-tubules are regularly organized in triads. Bars: a and c, 0.5 mm; b, 0.25 mm.conversely activated in the classical animal model of ALS only at
late stage of disease (Dobrowolny et al., 2008 and data not
shown).CellTaken together, these data suggest a feasible connection be-
tween SOD1G93A-mediated oxidative stress and autophagy. To
definitely prove the role of autophagy in the promotion of muscleMetabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc. 431
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Oxidative Stress Induces Muscle Atrophyatrophy, we performed functional in vivo gene transfer experi-
ments (Dona` et al., 2003) into the TA (Figure 5H) and EDL (data
not shown) myofibers of MLC/SOD1G93A adult skeletal muscle.
Using siRNA construct against LC3we demonstrated that the in-
activation of LC3 was sufficient to induce rescue of the muscle
phenotype (Figure 5H).
One of the unresolved questions related to autophagy con-
cerns the origin of the membrane that forms the sequestering
vesicle. It has been proposed that autophagosomes might initi-
ate from the modification of pre-existing structures (Wang and
Klionsky, 2003). EM ultrastructural analysis of the sarcotubular
system performed on MLC/SOD1G93A fiber revealed significant
alterations of internal (SR) and external (sarcolemma and trans-
verse-tubules) membranes. SR in MLC/SOD1G93A transgenic fi-
bers was often abnormally fragmented (Figure 5I), and similar
fragmented vesicles were also observed just below the sarco-
lemma (data not shown). These altered structures appear in
proximity of areas in which disrupted mitochondria appear to
be enveloped in membranous sacks (Figure 5Ia). In addition,
an unexpected alteration in the transverse (T)-tubule organiza-
tion was observed (Figure 5I). In WT muscle (data not shown),
T-tubules run perpendicularly (transversely) to the long axis of
the fiber and form junctions (or triads) with the SR terminal cis-
ternae (Franzini-Armstrong, 1970). Notably, in MLC/SOD1G93A
mutant muscle, T-tubules curved into an L-like structure
Figure 6. Muscle Expression of SOD1G93A
Mutant Gene Induces Presymptomatic
Sign of ALS without Causing Motor Neuron
Degeneration
(A) Lipid peroxidation, expressed as nmol of ma-
londialdehyde (MDA) per mg of protein, in the spi-
nal cord of wild-type (WT) (n = 5) and MLC/
SOD1G93A (Tg) (n = 5) mice. Values are mean ±
SEM (*p < 0.0005).
(B) Representative western blot and densitometric
analysis for SMI-32 expression in the ventral root
of WT and MLC/SOD1G93A (Tg) spinal cord.
(C) Quantification of surviving motor neurons in the
ventral spinal cord of WT and MLC/SOD1G93A (Tg)
mice.
(D) Immunofluorescence analysis of transverse
sections from soleus and EDL muscles of WT
and MLC/SOD1G93A (Tg) mice with antibodies
against MyHC-Fast. Bar = 100 mm.
(E) Tibialis anterior (TA) and soleus muscles of
4-month-old mice (WT and Tg) were transfected
with both Renilla pRL-TK construct and plasmid
bearing a luciferase reporter driven by the
MyHC1 promoter. Luciferase activity was mea-
sured in extracts from the muscles 1 week later.
(F–H) Real-time PCR of molecular markers of in-
flammatory response in the spinal cord of WT
(white bars) (n = 5) and Tg (black bars) (n = 5)
mice. Values are mean ± SEM (*p = 0.0146; **p <
0.005; ***p < 0.0001).
(Figure 5Ia) that progressed to a vesi-
cle-like structure encompassing amor-
phous cellular material (Figures 5Ib and
5Ic). These structures were clearly of
T-tubular origin since their association
with the SR was still evident and RyR-feet were still present be-
tween the two membranes (Figures 5Ib and 5Ic, small arrows).
Since ROS accumulation induced lipid peroxidation and sarco-
lemma damage (Figure 4A), it is reasonable to suggest that lipid
peroxidation involves the entire plasma membrane, including
T-tubules. Altered T-tubules (and possibly the SR) might be
therefore the donor of membrane that forms the sequestering
vesicles.
ROS Accumulation in Skeletal Muscle Inducing
Microglia Activation without Motor Neuron
Degeneration
One of the unresolved questions in ALS is whether muscle atro-
phy is directly induced by the toxic properties of muscle
SOD1G93A expression or whether it is a consequence of motor
neuron degeneration. On the other hand, ROS-mediated muscle
atrophy might retrogradely impact the nervous system and
cause motor neuron loss. To verify this hypothesis, we analyzed
specific targets of oxidative stress, such as lipid peroxidation, in
the spinal cords of MLC/SOD1G93A mice. MDA levels (Figure 6A)
were elevated in the MLC/SOD1G93A transgenic spinal cord
compared to WT controls, indicating an alteration in the plasma
membrane of motor neurons and suggesting that accumulated
ROS in MLC/SOD1G93A mutant muscle might influence and alter
motor neuron activity. To verify this hypothesis, we performed432 Cell Metabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc.
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cation in the ventral root of MLC/SOD1G93A spinal cord.
Western blots (Figure 6B) and immunohistochemical analysis
(Figure 6C) did not reveal significant changes in the number of
motor neurons, rather pointing to a causal link between local ac-
cumulation of ROS and muscle atrophy. Other factors associ-
ated with muscle denervation and ALS severity are Nogo-A
and Nogo-C (Jokic et al., 2006), whose expression, occurring
early in ALS skeletal muscle, could cause repulsion and destabi-
lization of the motor nerve terminals and subsequent dying back
of the axons and motor neurons. Real-time RT-PCR analysis
(data not shown) did not reveal significant change of Nogo-A
and Nogo-C expression between WT and MLC/SOD1G93A trans-
genic mice.
A shift in fiber composition constitutes another marker associ-
ated with muscle denervation (Schiaffino and Serrano, 2002).
Specifically, motor neuron degeneration and muscle denervation
cause a shift from slow to fast muscle phenotype. However,
quantitative analysis of fiber composition in EDL and soleus
muscles did not reveal significant differences between WT and
MLC/SOD1G93A transgenic adult mice (Figure 6D). This result
was confirmed by analyzing the activity of slow-MyHC promoter
(MyHC1-Luc) by in vivo functional electrotransfer (Figure 6E).
These data finally clarify that selective muscle accumulation of
SOD1G93A mutant protein does not induce motor neuron degen-
eration. Nevertheless, we analyzed in much detail whether and at
which level the muscle accumulation of SOD1G93A mutant pro-
tein and ROS impacts the nervous system. To this purpose we
performed several experiments, based on the evidence that al-
teration in microglial activation and subsequent altered inflam-
matory response are associated with the presymptomatic sign
of ALS and are independent from motor neuron degeneration
(Neusch et al., 2007).
It has been recently reported that ROS can cross the motor
neuron cell membrane and activate microglia, which respond
by releasing cytokines and further ROS (Barber et al., 2006).
To characterize microglial responses in the MLC/SOD1G93A
mutant mice, we analyzed the expression of ionized calcium-
binding adaptor molecule (Iba1), a specific marker of microglial
cells (Imai et al., 1996). Quantitative RT-PCR analysis revealed
a significant upregulation of Iba1 expression in the spinal cord
of MLC/SOD1G93A transgenic mice, compared with WT litter-
mates (Figure 6F). Notably, astrocyte activity, which normally in-
creases at a later stage of ALS disease, did not change between
WT and MLC/SOD1G93A spinal cord, as revealed by GFAP
Figure 7. A Summary of the Role of the
MLC/SOD1G93A Transgene in the Modula-
tion of Factors Involved in Muscle Atrophy
See text for details.
expression (data not shown). The activa-
tion of microglia can be correlated with
the expression of certain cytokines. In
the spinal cord of the classical SOD1G93A
mouse model, TGF-b1, M-CS, TNF-a,
and TNF-a receptor expression in-
creases in young presymptomatic mice
(Elliott, 2001). RT-PCR analysis (Figures 6G and 6H) revealed
that M-CSF, TGF-b1, INF-g, TNF-a, and TNF-a receptor expres-
sion accumulated in the spinal cord of MLC/SOD1G93A mice,
whereas their expression was maintained at low levels in the spi-
nal cord of age-matched WT mice (Figures 6G and 6H).
Our data therefore suggest that additional pathways must be
activated to trigger neuron degeneration and reinforce the evi-
dence that skeletal muscle dysfunctions before motor neuron
degeneration and the onset of clinical symptoms of ALS.
DISCUSSION
This study demonstrates that skeletal muscle is a direct target of
SOD1 mutation and that muscle-restricted expression of
SOD1G93A gene is sufficient to induce severe muscle atrophy
without evident sign of motor neuron degeneration. The original
discovery of SOD1 gene mutations in ALS patients immediately
prompted hypotheses of toxic gain-of-function effects on motor
neurons. However, the pathogenesis of ALS is emerging as
a ‘‘multisystemic’’ disease in which alterations in structural,
physiological, and metabolic parameters in different cell types
(motor neurons, glia, muscle) may act synergistically to exacer-
bate the disease, requiring a more directed approach to the anal-
ysis of aberrant SOD1 function in specific cell types. Although
mutant SOD1 is also expressed by muscle of ALS patients the
relative contribution of mutant SOD1 gene expression in skeletal
muscle has been debated (Miller et al., 2006).
Here we provide evidence for the local pathological impact of
SOD1 mutant gene (Figure 7). When overexpressed exclusively
in skeletal muscle, mutant SOD1G93A (1) induces accumulation
of ROS and sarcolemma damage, (2) causes dramatic muscle
atrophy with a concomitant alteration in the ultrastructure and
in the functional performance of skeletal muscles, and (3) pro-
motes a shift in the metabolic activity of muscle fibers.
The results of this study challenge the accepted dogma that
motor neuron degeneration, caused by transgenic SOD1G93A
overexpression, is the primary cause of muscle atrophy.
Muscle atrophy represents one of the earliest events detect-
able in the SOD1G93A ubiquitous transgenic animals (Brooks
et al., 2004), followed by alteration of the neuromuscular junc-
tion, retrograde axonal degeneration, and lastly motor neuron
death. This sequential pattern of degeneration suggests that cer-
tain muscle abnormalities precede motor neuron death rather
than resulting from it. Our results confirm that local oxidative
stress is a primary determinant of ALS-associated muscleCell Metabolism 8, 425–436, November 5, 2008 ª2008 Elsevier Inc. 433
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from motor neuron degeneration.
At first glance it would appear that the present study contra-
dicts the work of Miller and coworkers (Miller et al., 2006), who
reported that muscle is not a primary target for non-cell-autono-
mous toxicity in familial ALS. Their argument was based on the
evidence that partial suppression of mutant protein accumula-
tion within SOD1G93A mouse muscle, using a lentivirus that en-
codes an siRNA directed against mutant SOD1, or by muscle
selective SOD1 mutant gene excision, did not delay the progres-
sion of the disease. Since we show that even low levels of local
MLC/SOD1G93A expression were sufficient to cause muscle at-
rophy and alteration in functional performance (Figures 2 and
3), both studies are consistent with the adverse effects of oxida-
tive stress on muscle homeostasis.
How does oxidative stress induce muscle atrophy? Our exper-
iments suggest that ROS production activates FoxO3, NFkB,
and autophagic signaling (Figure 7). While FoxO3 modulates
both atrogin and MuRF1, NFkB acts selectively on MuRF1. The
action of FoxO is partly inhibited by PGC1a (Figure 7), a factor
that is induced by oxidative stressors and that represents an im-
portant regulator of intracellular ROS levels. The activation of
PGC1a also induces and coordinates gene expression that stim-
ulates fiber-type switching and metabolic pathways, reflected in
the increase in the number of mitochondria and therefore the
shift from glycolytic to oxidative metabolism of MLC/SOD1G93A
transgenic muscle fibers.
It has also been reported that FoxO3 not only activates ubiq-
uitin ligases but is also necessary and sufficient for the induction
of the catabolic pathway known as autophagy (Figure 7) (Mam-
mucari et al., 2007). The critical role of autophagy in the promo-
tion of muscle atrophy was disclosed by genetic manipulation of
LC3 expression, suggesting that the modulation of autophagy
can be a potential therapeutic intervention to counteract muscle
atrophy associated with oxidative stress.
Although the mechanism whereby muscle contributes to ALS-
associated motor neuron degeneration is still unclear, it is likely
that toxic signals originating from skeletal muscle compromise
the functional connection of muscle and nerve.
However, systemic interventions on several cell types are nec-
essary to develop ALS disease and to trigger neuronal degener-
ation. Establishment of the myocyte as a direct target of the toxic
properties of a mutant SOD1 variant provides important insights
into the atrophic effects of oxidative stress in ALS disease.
EXPERIMENTAL PROCEDURES
Generation of MLC/SOD1G93A Transgenic Mice
We subcloned both the SOD1G93A and WT SOD1 cDNAs into the pMex plas-
mid containing the regulatory elements of the MLC1f/3f gene (Figure 1A). FVB
mice (Jackson Laboratories) were used as embryo donors. Positive founders
were subsequently bred to FVB WT mice. Transgenic mice were selected by
PCR using tail digests. The animals were housed in a temperature-controlled
(22C) room with a 12:12 hr light-dark cycle. All of the mice were maintained
according to the institutional guidelines of the animal facilities of DIEM-
National Institute of Health-Italy.
RNA Preparation and Northern Blot Analysis
We obtained total RNA from WT and MLC/SOD1G93A transgenic muscles by
TRIzol reagent (Invitrogen); 15 mg of RNA were fractionated by electrophoresis
on 1.3% agarose gels and hybridized.434 Cell Metabolism 8, 425–436, November 5, 2008 ª2008 ElsevierProtein Extraction and Western Blot Analysis
Protein extraction from both WT and MLC/SOD1G93A transgenic muscles was
performed in lysis buffer (50 mM Tris-HCl pH7.4, 1% w/v Triton x100, 0.25%
sodium deoxycholate, 150 mM sodium chloride, 1 mM phenylmethylsulfonyl
fluoride, 1 mg/ml aprotinin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mM sodium
orthovanadate, 1 mM sodium fluoride). Equal amounts of protein from each
muscle lysate were separated in SDS polyacrilamide gel and transferred
onto a nitrocellulose membrane. Filters were blotted with antibodies against
human-SOD (BD Pharmigen), FoxO, NFkB, pNFkBSer 536 (Cell signaling),
SMI-32 (AbCam), a-tubulin, and actin (Sigma).
Histological and Immunofluorescence Analysis
Segments of TA, EDL, and soleus muscles from WT and MLC/SOD1G93A
transgenic mice were embedded in tissue freezing medium and snap frozen
in nitrogen-cooled isopentane and stained for either NADH-transferase or
hematoxylin and eosin.
Additional muscle frozen sections (7 mm) were used for immunofluorescence
analysis and processed as described in Dobrowolny and coworkers (2005).
Monoclonal antibodies against myosin heavy chain (MyHC) I and II were
used; nuclei were visualized using Hoechst staining.
For motor neuron quantification, fixed spinal cord slices were immuno-
stained with SMI-32 monoclonal antibody. Inverted microscope (Axioskop 2
plus; Carl Zeiss MicroImaging, Inc.), using 20 or 403 lenses, was used and im-
ages were processed using Axiovision 3.1.
Morphometric Analysis and Statistics
A minimum of four random fields (corresponding to 400 cross-sectioned fibers)
were photomicrographed for each muscle and mouse (n = 5/genotype); all
type fibers were analyzed using Scion Image software (v. Beta 4.0.2, Scion,
Frederick, MD). Statistical analysis was performed with GraphPad Prism
v4.0 software; groups were compared by Mann-Whitney Rank Sum test and
the difference in the median values between the two groups was considered
significant for p value < 0.05.
Analysis of Oxidative Stress
Protein carbonyl content (Cayman Chemical) was measured by forming la-
beled protein hydrazone derivatives, using 2,4-dinitrophenylhydrazide
(DNPH), and quantified spectrophotometrically (Mecocci et al., 1999). Results
are expressed as nmol of DNPH per mg of proteins. MDA dosage was per-
formed by means of a HPLC system with fluorometric detection (Mecocci
et al., 1999). MDA forms an adduct with thiobarbituric acid (TBA) that is mea-
sured by spectrophotometry (OXItek TBARS Assay Kit; ZeptoMetrix Corpora-
tion). Results are expressed as nmol of MDA per mg of proteins.
Antioxidant Enzymes Activities
The antioxidant enzyme assays were performed, as previously detailed (Fano`
et al., 2001). Muscle tissue was homogenized in ten volumes of 20 mM Na-
phosphate buffer pH 7.0 + 1 mg/ml pepstatin, 1 mg/ml leupeptin, and 100 mM
phenylmethylsulfonyl fluoride (PMSF) as protease inhibitors and centrifuged
at 100,0003 g for 1 hr at 4C. Cytosol proteins were measured on the resulting
supernatant according to the Lowry’s method. Superoxide dismutase (SOD)
activity was determined using the modified method by Fulle and coworkers
(Fulle et al., 2000). Catalase (Cat) activity was determined, analyzing the de-
crease in absorbance due to H2O2 consumption (3 = 0.04 mM1 cm1)
measured at 240 nm. The final reaction volume was 1 ml and contained
100 mM Na-phosphate buffer pH 7.0, 12 mM H2O2, and 70 mg of protein lysate.
Glutathione S-transferase (GSt) activity was determined by using 1-cloro-2-4-
dinitrobenzene (CDNB) as substrate. The assay was performed at 340 nm (3 =
9.6 mM1 cm1) in a final volume of 1 ml containing 100 mM Na-phosphate
buffer pH 6.5, 1 mM CDNB, 1 mM reduced glutathione (GSH), and 30 mg of
protein lysate. Glutathione reductase (GR) activity was measured by the
rate of decrease in absorbance, induced by NADPH oxidation, at 340 nm
(3 = 6.22 mM1 cm1). The assay mixture contained, in a final volume of
1 ml, 100 mM Na-phosphate buffer pH 7.0, 1 mM glutathione disulphide
(GSSG), 60 mM NADPH, and 100 mg of protein lysate.Inc.
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MLC/SOD1G93A transgenic mice (n = 6) were treated daily for 15 days with
30 mg/kg of Trolox intraperitoneally.
Mechanical Measurements
EDL and soleus muscles were isolated from 4-month-old WT and transgenic
mice and transferred to a dissecting chamber, containing Krebs-Ringer solu-
tion at room temperature (RT) equilibrated with 5% CO2-95% O2 (pH 7.30). The
proximal tendon was fixed to a clamp and the distal tendon to a force trans-
ducer (model Aurora Scientific Instruments 300B).
The isolated muscle was electrically stimulated by means of two platinum
electrodes, located 2 mm from each side of the muscle, with 200 mA controlled
current pulses (Del Prete et al., 2008). Optimum muscle length was adjusted to
the length (L0) that produced the highest twitch force. Maximum tetanic force
was measured with a train of pulses delivered at 180 Hz for EDL and 60 Hz for
soleus. Specific force was computed as maximum force divided by muscle
weight. To evaluate mechanical work the muscle was repeatedly stimulated
in isotonic conditions with a series of 0.1 ms pulses (120 Hz for EDL and
60 Hz for soleus), delivered in trains of 0.4 s duration, repeated every 1 s
(Del Prete et al., 2008). In this phase the muscle shortened against a load equal
to one-third of its own maximum force. This value was chosen because it has
been shown that unfatigued muscles generate their maximum power at that
force level (Vedsted et al., 2003). Mechanical work was calculated by multiply-
ing the constant load with the displacement measured during each contraction.
RNAi and Adult Mouse Skeletal Muscle Transfection
In vivo RNAi experiments were performed as previously described (Sandri
et al., 2004), using the sequence (actctgatgcactaataaa) that targets regions
in the mouse LC3 gene, and RNAi was cloned into pSUPER vector bearing
the GFP reporter gene; mice were sacrificed 7 and 21 days after transfection.
CSA of GFP-positive and GFP-negative fibers were measured as described in
Morphometric Analysis and Statistics section.
Electron Microscopy
EDL and TA muscles were carefully dissected from transgenic and WT mice
(4 months of age). Muscles were fixed immediately at RT in 3.5% glutaralde-
hyde in 0.1 M Na cacodylate buffer, pH 7.2, for 2 hr. Small bundles of fixed fi-
bers were then post-fixed in 2% OsO4 in the same buffer for 2 hr and block-
stained in aqueous saturated uranyl acetate. Ultra thin sections were cut in
a Leica Ultracut R microtome (Leica Microsystem, Vienna, Austria) using a Dia-
tome diamond knife (DiatomeLtd. CH-2501 Biel, Switzerland). Sections, after
staining in 4% uranyl acetate and lead citrate, were examined with a Morgagni
Series 268D electron microscope (FEI Company, Brno, Czech Republic),
equipped with Megaview III digital camera.
RNA Extraction and Quantitative RT-PCR
Total RNA (1 mg) was treated with DNase I Amplification Grade (Invitrogen) and
reverse-transcribed using the SuperScript III (Invitrogen). Quantitative PCR
was performed using the ABI PRISM 7000 SDS (Applied Biosystems, USA),
and iTaqSupermix with rox (Biorad). All primers were optimized for real-time
RT-PCR amplification, checking the generation of a single amplicon in a melt-
ing curve assay and the efficiency in a standard curve amplification (>98% for
each couple of primers). Quantitative RT-PCR sample value was normalized
for the expression of 18 s mRNA. The relative level for each gene was calcu-
lated using the 2-DDCt method (Livak and Schmittgen, 2001) and reported as
arbitrary units.






Cathepsin L: 50gtggactgttctcacgctcaag30 50tccgtccttcgcttcatagg30.
Statistical Analysis
All data, if not differently specified, were compared using Student’s t test, with
p < 0.05 being considered statistically significant.Cell MACKNOWLEDGMENTS
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